In the absence of effective regulation, Th1 CD4+ T cell responses can target self-peptides, resulting in autoimmune diseases such as Type 1 diabetes (T1D) [71], Rheumatoid Arthritis (RA) [72], and Systemic Lupus Erythematosus (SLE) [72]. This evidence concerns the gene CD4 and rheumatoid arthritis.